Oxford Square Capital (NASDAQ:OXSQ – Get Free Report) is set to issue its quarterly earnings data before the market opens on Tuesday, November 5th.
Oxford Square Capital (NASDAQ:OXSQ – Get Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The company reported $0.13 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.13. The firm had revenue of $11.45 million during the quarter. Oxford Square Capital had a return on equity of 18.70% and a net margin of 6.05%. During the same quarter in the previous year, the business posted $0.13 earnings per share.
Oxford Square Capital Price Performance
Shares of NASDAQ:OXSQ opened at $2.93 on Monday. Oxford Square Capital has a 1 year low of $2.74 and a 1 year high of $3.29. The business’s 50-day moving average is $2.89 and its 200-day moving average is $3.00. The company has a market capitalization of $186.82 million, a price-to-earnings ratio of 97.70 and a beta of 1.10.
Oxford Square Capital Dividend Announcement
Wall Street Analysts Forecast Growth
Separately, StockNews.com raised Oxford Square Capital from a “sell” rating to a “hold” rating in a research report on Wednesday, August 14th.
Get Our Latest Stock Report on Oxford Square Capital
Oxford Square Capital Company Profile
Oxford Square Capital Corp. is a business development company, operates as a closed-end, non-diversified management investment company. It is a private equity and mezzanine firm. The firm invests in both public and private companies. It invests in secured and unsecured senior debt, subordinated debt, junior subordinated debt, preferred stock, common stock and syndicated bank loans.
See Also
- Five stocks we like better than Oxford Square Capital
- How to Use High Beta Stocks to Maximize Your Investing Profits
- November’s Small-Cap Treasures: 3 Stocks Poised for Growth
- Overbought Stocks Explained: Should You Trade Them?
- Bright Future for Clean Hydrogen Stocks? Analysts Are Watching
- Why Are Stock Sectors Important to Successful Investing?
- High-Yield AbbVie Gains Momentum: A 20% Upside Is in Sight
Receive News & Ratings for Oxford Square Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Square Capital and related companies with MarketBeat.com's FREE daily email newsletter.